References
- Engström-Laurent A, Laurent U BG, Lilja K, Laurent T C. Concentration of sodium hyaluronate in serum. Scand. J. Clin. Lab. Invest. 1985; 45: 497–504
- Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay for the carboxyterminal propeptide of human type I procollagen (PICP), Submitted for publication
- Niemelä O, Risteli L, Sotaniemi E A, Risteli J. Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur. J. Clin. Invest. 1985; 15: 132–136
- Risteli J, Risteli L. Markers of collagen assembly and turnover. Clinical impact of bone and connective tissue markers, E Lindh, J Thorell. Academic Press, London 1989; 201–209
- Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat A P, Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin. Chem. 1988; 34: 715–718
- Risteli L, Risteli J. Noninvasive methods for detection of organ fibrosis. Connective tissue in health and disease, M Rojkind. CRC Press, Boca Raton 1990; 61–98
- Robins S P, Stewart P, Astbury C, Brid H A. Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease. Ann. Rheum. Dis. 1906; 45: 969–973
- Rohde H, Vargas L, Hahn E, Kalbfleisch H, Bruguera M, Timpl R. Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur. J. Clin. Invest. 1979; 9: 451–459
- Schuppan D, Besser M, Schwarting R, Hahn E G. Radioimmunoassay for the carboxyterminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. J. Clin. Invest. 1986; 78: 241–248
- Taubman M B, Goldberg B, Sherr C J. Radioimmunaossay for human procollagen. Science 1974; 186: 1115–1117